Kane Biotech Inc.
TSX VENTURE : KNE

Kane Biotech Inc.

July 04, 2005 09:40 ET

Kane Biotech Announces Director Resignation

WINNIPEG, MANITOBA--(CCNMatthews - July 4, 2005) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development of products to prevent and disperse bacterial biofilms, announces the resignation of Kelvin Maloney as a director of the Company effective June 30, 2005.

Mr. Maloney, an appointee of the Manitoba Science and Technology Fund Limited Partnership (the "Fund"), has stepped down from the Board due to the fact he is no longer a representative of the Fund.

The Board of Directors of Kane Biotech Inc. would like to take this opportunity to thank Mr. Maloney for his valuable contributions to the Company through his participation on the Board.

The Company continues to have a majority of independent directors and does not currently anticipate appointing a replacement.

About Kane Biotech Inc.

Kane Biotech is a biotechnology company engaged in the development of products to prevent and disperse bacterial biofilms. The Company is developing products for the prevention and dispersal of biofilms focused on the genetic mechanisms of biofilm formation.

Certain information contained in this press release may be forward-looking and is subject to risks and uncertainties. Although the Company believes that the expectations contained herein are reasonable, it can give no assurances such forward-looking statements will prove correct. Information is provided from sources deemed to be reliable.

The TSX Venture Exchange has neither approved nor disapproved the contents of this press release.

Contact Information